Investors eyeing a purchase of BioCryst Pharmaceuticals Inc (BCRX - Get Report) shares, but tentative about paying the going market price of $5.52/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the September put at the $4 strike, which has a bid at the time of this writing of 40 cents. Collecting that bid as the premium represents a 10% return against the $4 commitment, or a 18.9% annualized rate of return (at Stock Options Channel we call this the YieldBoost).Selling a put does not give an investor access to BCRX's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $4 strike if doing so produced a better outcome than selling at the going market price. ( Do options carry counterparty risk? This and six other common options myths debunked). So unless BioCryst Pharmaceuticals Inc sees its shares decline 27.4% and the contract is exercised (resulting in a cost basis of $3.60 per share before broker commissions, subtracting the 40 cents from $4), the only upside to the put seller is from collecting that premium for the 18.9% annualized rate of return. Below is a chart showing the trailing twelve month trading history for BioCryst Pharmaceuticals Inc, and highlighting in green where the $4 strike is located relative to that history: The chart above, and the stock's historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the September put at the $4 strike for the 18.9% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for BioCryst Pharmaceuticals Inc (considering the last 251 trading day closing values as well as today's price of $5.52) to be 66%. For other put options contract ideas at the various different available expirations, visit the BCRX Stock Options page of StockOptionsChannel.com.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Stocks
Beyond Meat Sizzles Following Launch of 'Beyond Beef' Product
Beyond Meat's new plant-based ground meat is made without GMOs, soy or gluten.
Micron's Unexpected Move Higher Boosts Semiconductor Sentiment
Micron is motivating more positive outlook on the semiconductor sector's road ahead.
AbbVie's Allergan Deal Sets Up Another Trade In Big Biotech
The drop in AbbVie's stock price following revelation of its plans to buy Allergan provides a way to hit a solid investment single using a buy-write options strategy.
Micron Looks Higher for the Open but the Charts Could Use More Strength
Let's check the charts this morning ahead of the open, imagining strength to the $35.50 area.